Can you switch from Opdivo to Keytruda? Navigating Immunotherapy Treatment Changes
•
5 min read
While both Opdivo (nivolumab) and Keytruda (pembrolizumab) are potent PD-1 inhibitors, clinical guidelines generally don't recommend switching between them solely for lack of efficacy because their mechanisms are so similar. However, a switch from Opdivo to Keytruda is sometimes considered under specific medical circumstances, most notably for managing severe or intolerable side effects.
